For Class II and III medical devices, NMPA registration often involves multiple quality inspections throughout the product lifecycle, from initial registration to post-market surveillance and renewal. For Class I devices, the inspection process is generally less intensive, focusing more on document review and less on manufacturing site inspections. However, all manufacturers, regardless of device class, must ensure ongoing compliance with NMPA regulations to maintain market access in China.